A detailed history of First Horizon Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, First Horizon Corp holds 336 shares of EXAS stock, worth $21,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
336
Holding current value
$21,336
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$40.91 - $56.0 $13,745 - $18,816
336 New
336 $18,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.